
- August 2019 Back to School
- Volume 85
- Issue 8
The Role of the Pharmacist With Cholesterol Management: Focusing on New Guidelines and PCSK9 Inhibitors
Continuing education for managing cholesterol with PCSK9 inhibitors.
Faculty
Joseph J. Saseen, PharmD, BCPS, BCACP, CLS, Professor and Vice Chair, Department of Clinical Pharmacy; Professor, Department of Family Medicine; University of Colorado Anschutz Medical Campus, Aurora Colorado
Educational Objectives
At the completion of this activity, the participant will be able to:
- Examine the pathophysiology, complications, and burden associated with hypercholesterolemia
- Identify updates to guidelines and the appropriate role of PCSK9 inhibitors in the management of hypercholesterolemia
- Explore various ways that pharmacists can make an impact and provide education for patients with hypercholesteremia to optimize outcomes
Target Audience: Pharmacists
Activity Type: Application
Release Date: August 12, 2019
Expiration Date: August 12, 2020
Estimated Time to Complete Activity: 2.0 hours
Fee: This lesson is offered for free at
Articles in this issue
about 6 years ago
A Hospital and Physician Share Liability for Prescribing Opioidsabout 6 years ago
Motivational Interviewing Offers a Path to Improved Adherenceabout 6 years ago
Drug Shortages Raise Critical Safety Concernsabout 6 years ago
Case Study: Albuterolabout 6 years ago
340B Specialists Help Maintain Program Integrityabout 6 years ago
How Can Patients Prevent and Treat Fall Allergies?about 6 years ago
Case Study: Vitamins for Eye Healthabout 6 years ago
Pet Peeves (August 2019)Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.